Your search history is turned on.
Date: December 21, 2017 Jurisdictions: Alberta, British Columbia
FORM 62-103F1 REQUIRED DISCLOSURE UNDER THE EARLY WARNING REQUIREMENTS State if the report is filed to amend information disclosed in an earlier report. Indicate the date of the report that is being amended. n/a Item 1 Security and Reporting Issuer 1.1 State the designation of securities to which this report relates and...
EPICORE BIONETWORKS INC. NOTICE OF CHANGE IN CORPORATE STRUCTURE Pursuant to Section 4.9 of National Instrument 51-102 Continuous Disclosure Obligations Item 1 Name of the Parties to the Transaction Epicore BioNetworks Inc. (Epicore) Neovia Probiotics Inc. (Acquiror) Neovia S.A.S. (Neovia) Item 2 Description of the Transaction...
Date: December 18, 2017 Jurisdictions: All jurisdictions
Epicore BioNetworks Inc. and Neovia S.A.S. jointly announce completion of an arrangement involving Epicore, its security holders and Neovia Probiotics Inc. ("Neovia"), a wholly owned subsidiary of Neovia S.A.S. Epicore BioNetworks Inc. and Neovia S.A.S. jointly announce completion of an arrangement involving Epicore, its security holders and Neovia Probiotics Inc. ("Neovia"), a wholly owned subsidiar...
Date: December 13, 2017 Jurisdictions: All jurisdictions
Shareholders of Epicore BioNetworks Inc. Overwhelmingly Approve Proposed Transaction with Neovia Probiotics Inc. ("Neovia"), a wholly owned subsidiary of Neovia S.A.S. Shareholders of Epicore BioNetworks Inc. Overwhelmingly Approve Proposed Transaction with Neovia Probiotics Inc. ("Neovia"), a wholly owned subsidiary of Neovia S.A.S. EASTAMPTON, NJ, Dec. 13, 20...
Date: November 22, 2017 Jurisdictions: Alberta, British Columbia
Microsoft Word - C6045002.DOC EPICORE BIONETWORKS INC. Notice of Special Meeting to be held on December 13, 2017 - and - Notice of Originating Application to the Court of Queen's Bench of Alberta - and - Management Information Circular With respect to the ACQUISITION of EPICORE BIONETWORKS INC. by NEOVIA PROBIOTICS INC. an in...
Microsoft Word - C6064410.DOCX FORM OF PROXY FOR COMMON SHAREHOLDERS THIS PROXY IS SOLICITED BY AND ON BEHALF OF MANAGEMENT FOR THE SPECIAL MEETING OF THE SHAREHOLDERS OF EPICORE BIONETWORKS INC. TO BE HELD ON DECEMBER 13, 2017 This Proxy ("Proxy") is solicited by and on behalf of Management of Epicore BioNetworks Inc. ("Epicore") for use at the special mee...
Microsoft Word - C6073404.DOC EPICORE BIONETWORKS INC. NOTICE OF SPECIAL MEETING OF EPICORE SHAREHOLDERS NOTICE IS HEREBY GIVEN that, pursuant to an order (the "Interim Order") of the Court of Queen's Bench of Alberta dated November 7, 2017, a special meeting (the "Meeting") of the holders ("Epicore Shareholders") of common shares ("Epicore Shares") of Epicore Bio...
Microsoft Word - C6064411.DOC THIS LETTER OF TRANSMITTAL FORM IS FOR USE BY REGISTERED HOLDERS OF COMMON SHARES OF EPICORE BIONETWORKS INC. ("EPICORE") ONLY IN CONJUNCTION WITH THE PLAN OF ARRANGEMENT INVOLVING EPICORE, ITS SHAREHOLDERS, HOLDERS OF OPTIONS OF EPICORE AND NEOVIA PROBIOTICS INC. THIS LETTER OF TRANSMITTAL MUST BE VALIDLY COMPLETED, DULY EXE...
Date: November 16, 2017 Jurisdictions: All jurisdictions
Microsoft Word - SEDAR11161372E00005264(20171116T163530).html Epicore BioNetworks Inc. Reports Results for Q1 Fiscal Year 2018 for the quarter ended 30 September 2017, in US dollars EASTAMPTON, NJ, Nov. 16, 2017 /CNW/ - Revenue for Q1 at $2.8 million was 15% higher than last year's Q1, setting a new Q1 sales record. Sales increases were achieved in several area...
Date: November 16, 2017 Jurisdictions: Alberta, British Columbia
Managements Discussion and Analysis Of Financial Condition and Results of Operations For the three months ended: September 30, 2017 Fiscal Year 2018, Quarter One - 2 - As previously...